Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU1Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $128,100
Award facts
- Contract value 100% obligated
- $128,099.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $128k to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400-milliliter vials, with a firm fixed-price structure. The award, issued on January 12, 2026, is non-competitive and carries an ultimate completion date of February 3, 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract reflects the critical role AmerisourceBergen plays in the federal pharmaceutical supply chain, particularly in supporting military treatment facilities and veterans' healthcare systems. Gamunex-C is an intravenous immunoglobulin product commonly used for immunodeficiency disorders and autoimmune conditions, making this award consistent with the company's established portfolio of delivering specialized medical commodities across multiple therapeutic domains to the Department of Defense and related federal health agencies. The short completion timeline and firm fixed pricing indicate a routine replenishment order under the existing IDC vehicle.
Quick answers
Who was awarded contract SPE2DR26FQU1Y?
SPE2DR26FQU1Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU1Y worth?
The government has obligated $128,100 on SPE2DR26FQU1Y.
Is contract SPE2DR26FQU1Y an order under another contract?
Yes. SPE2DR26FQU1Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU1Y competed?
The extent of competition for SPE2DR26FQU1Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award